Prot: AUR-VCS-2017-03: An Open-Label Dose-Exploration Cohort Study Evaluating the Efficacy and Safety of Voclosporin in Achieving Complete or Partial Remission of Proteinuria in Subjects with Focal Segmental Glomerulosclerosis

Project: Research project

Project Details

Effective start/end date8/14/198/14/22


  • CTI Clinical Trial and Consulting Services (Prot: AUR-VCS-2017-03 // Prot: AUR-VCS-2017-03)
  • Aurinia Pharmaceuticals Inc. (Prot: AUR-VCS-2017-03 // Prot: AUR-VCS-2017-03)